Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지
DOI QR코드

DOI QR Code

The Effects of Plasma Endotoxin Level on Survival Time of Terminally Ill Cancer Patients

말기암환자에서 혈장 내독소 농도가 생존기간에 미치는 영향

  • Lee, Jin-Ah (Department of Family Medicine, Korea University College of Medicine) ;
  • Yoon, Ho Min (Department of Family Medicine, Korea University College of Medicine) ;
  • Choi, Youn Seon (Department of Family Medicine, Korea University College of Medicine) ;
  • Yeon, Jong Eun (Department of Internal Medicine, Korea University College of Medicine) ;
  • Lee, June Young (Department of Biostatistics, Korea University College of Medicine)
  • 이진아 (고려대학교 의과대학 가정의학교실) ;
  • 윤호민 (고려대학교 의과대학 가정의학교실) ;
  • 최윤선 (고려대학교 의과대학 가정의학교실) ;
  • 연종은 (고려대학교 의과대학 내과학교실) ;
  • 이준영 (고려대학교 의과대학 통계학교실)
  • Received : 2013.08.26
  • Accepted : 2014.03.13
  • Published : 2014.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Since most terminally ill cancer patients die of multiple organ failure, plasma endotoxin concentration levels may be used to predict the life expectancy. This study was performed to evaluate the clinical significance of endotoxin level in plasma as a prognostic factor for survival in patients with terminal cancer. Methods: This study was conducted with 56 terminally ill cancer patients, above 20 years old, from April 2009 through October 2009. Demographic characteristics, Karnofsky performance status, and survival time were evaluated. We analyzed blood levels of white blood cell hemoglobin, hematocrit, aspartate aminotransferase, alanine aminotransferase, c-reactive protein, total bilirubin and endotoxin in each patient. Results: We considered following variable for univariate analysis: plasma endotoxin level, sex, age, WBC, hemoglobin, hematocrit, AST, ALT, total bilirubin, CRP and severity of pain. Univariate analysis did not show a significant association between plasma endotoxin level and survival time. However, in a multivariate analysis with factors that were found to be significantly associated with survival sex, WBC count and total bilirubin level in univariate analysis, high levels of plasma endotoxin and short survival time were significantly related. Conclusion: Plasma endotoxin level could be used as a prognostic factor to predict the life expectancy of terminally ill cancer patients.

목적: 말기암환자의 여명 예측은 치료의 이득과 위해를 판단하는 잣대가 되고, 적절한 의료 중재 제공 및 환자의 자율성에 기초한 의사결정에 중요한 기준이 된다. 특히 많은 수의 말기암환자는 다발성 장기 부전으로 사망에 이르기 때문에 본 연구에서는 이를 반영할 수 있는 혈장 내독소 농도와 생존기간과의 연관성을 알아보고자 하였다. 방법: 2009년 4월부터 10월까지 6개월 동안, 만 20세 이상의 말기암환자 56명을 대상으로 혈장 내독소 농도를 측정하고, 생존기간을 조사하였다. 나이, 성별, 원발 암 부위, 암 치료 경력, 전이여부, 투약상황 및 활력 증후, Karnofsky 수행지수 등의 신체검사, 백혈구 수, 혈색소, 적혈구용적률, aspartate aminotransferase, alanine aminotransferase C-반응성 단백질, 총 빌리루빈, 내독소 등의 혈액검사를 시행하였다. 결과: 혈장 내독소 농도, 성별, 나이, 백혈구 수, 혈색소, 적혈구 용적률, AST, ALT, 총 빌리루빈, C-반응성 단백질, 통증강도를 단변량 분석한 결과 혈장 내독소 농도는 생존기간과 통계적으로 유의한 관계를 보이지는 않았으나, 단변량 분석에서 생존기간에 유의한 영향을 미치는 성별, 백혈구 수, 총 빌리루빈을 포함하여 시행한 다변량 분석에서 혈장 내독소 농도는 생존기간과 통계적으로 유의한 관계가 있는 것으로 나타났다. 결론: 다발성 장기 부전과 관련이 있는 혈장 내독소 농도는 생존기간 예측인자로서 쓰일 수 있는 가능성을 보여 주었다.

Keywords

References

  1. Korea National Statistical Office. 2007 statistical result of death and cause of death [internet]. Daejeon: Statistics Korea; 2008. [cited 2010 May 7]. Available from: http://www.index.go.kr.
  2. Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 2000;320:469-72. https://doi.org/10.1136/bmj.320.7233.469
  3. Lamont EB, Christakis NA. Some elements of prognosis in terminal cancer. Oncology (Williston Park) 1999;13:1165-70;discussion 1172-4, 1179-80.
  4. Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer 2002;94: 2733-7. https://doi.org/10.1002/cncr.10530
  5. Lamont EM, Siegler M. Paradoxes in cancer patients’ advance care planning. J Palliat Med 2000;3:27-35. https://doi.org/10.1089/jpm.2000.3.27
  6. Steensma DP, Loprinzi CL. The art and science of prognosis in patients with advanced cancer. Eur J Cancer 2000;36:2025-7. https://doi.org/10.1016/S0959-8049(00)00290-2
  7. Viganò A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 1999;86:170-6. https://doi.org/10.1002/(SICI)1097-0142(19990701)86:1<170::AID-CNCR23>3.0.CO;2-S
  8. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998;279: 1709-14. https://doi.org/10.1001/jama.279.21.1709
  9. Suh SY. Survival prediction of terminally iIll cancer patients. Korean J Hosp Palliat Care 2007;10:171-7.
  10. Geissbuhler P, Mermillod B, Rapin CH. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage 2000;20:93-103. https://doi.org/10.1016/S0885-3924(00)00169-X
  11. McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McCardle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001;41:64-9. https://doi.org/10.1080/01635581.2001.9680613
  12. Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 1999;17:231-9. https://doi.org/10.1016/S0885-3924(98)00145-6
  13. Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Gramazio A, et al. Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1997;13:1-9. https://doi.org/10.1016/S0885-3924(96)00265-5
  14. Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC. Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 1993;7:199-204. https://doi.org/10.1177/026921639300700306
  15. Suh SY, Ahn HY. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J cancer 2007;43:1051-9. https://doi.org/10.1016/j.ejca.2007.01.031
  16. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3:169-76. https://doi.org/10.1038/nri1004
  17. Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 1994;19:480-8. https://doi.org/10.1002/hep.1840190229
  18. Hartung T, Wendel A. Endotoxin-inducible cytotoxicity in liver cell cultures-I. Biochem Pharmacol 1991;42:1129-35. https://doi.org/10.1016/0006-2952(91)90298-J
  19. Wig JD, Kochhar R, Ray JD, Krishna Rao DV, Gupta NM, Ganguly NK. Endotoxemia predicts outcome in acute pancreatitis. J Clin Gastroenterol 1998;26:121-4. https://doi.org/10.1097/00004836-199803000-00007
  20. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Konigsrainer A, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;138:1452-5. https://doi.org/10.1093/jn/138.8.1452
  21. Buttenschoen K, Kornmann M, Berger D, Leder G, Beger HG, Vasilescu C. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg 2008; 393:473-8. https://doi.org/10.1007/s00423-008-0317-3
  22. Sunil VR, Patel KJ, Nilsen-Hamilton M, Heck DE, Laskin JD, Laskin DL. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Exp Mol Pathol 2007; 83:177-87. https://doi.org/10.1016/j.yexmp.2007.03.004
  23. Berger D, Schmidt UM, Ott S, Seidelmann M, Martin R, Beger HG. Incidence and pathophysiological relevance of postoperative endotoxemia. FEMS Immunol Med Microbiol 1995;11:285-90. https://doi.org/10.1111/j.1574-695X.1995.tb00158.x
  24. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14. https://doi.org/10.1056/NEJM199901213400307
  25. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998;26:2078-86. https://doi.org/10.1097/00003246-199812000-00045
  26. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE. Endotoxemia in human septic shock. 1991. Chest 1991;99: 169-75. https://doi.org/10.1378/chest.99.1.169
  27. Lundin JI, Checkoway H. Endotoxin and cancer. Environ Health Perspect 2009;117:1344-50. https://doi.org/10.1289/ehp.0800439
  28. Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol. 2004;286:G515-20. https://doi.org/10.1152/ajpgi.00475.2003
  29. Lee KK, Yum KS. Association of endotoxins and colon polyp: a case-control study. J Korean Med Sci. 2012;27:1062-5. https://doi.org/10.3346/jkms.2012.27.9.1062
  30. Chung JH, Kang MK, Rho JS, Yum KS. The association between visceral fat and endotoxin. Korean J Obes 2010;19:78-84.
  31. Jung HH, Yoon H, Choi YS Choi, Lee JY, Yeon JE. The correlation of plasma endotoxin and components of systemic inflammatory response syndrome in terminally ill cancer patients. Korean J Clin Geri 2013;14:39-48.
  32. Shin HS, Lee HR, Lee DC, Shim JY, Cho KH, Suh SY. Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients. J Pain Symptom Manage 2006;31:493-501. https://doi.org/10.1016/j.jpainsymman.2005.11.014
  33. Astrakianakis G, Seixas N, Camp J, Smith TJ, Bartlett K, Checkoway H. Cotton dust and endotoxin levels in three Shanghai textile factories: a comparison of samplers. J Occup Environ Hyg. 2006;3:418-27. https://doi.org/10.1080/15459620600793672
  34. Werling D, Jungi TW. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 2003;91: 1-12. https://doi.org/10.1016/S0165-2427(02)00228-3
  35. Schmidt C. Immune system's Toll-like receptors have good opportunity for cancer treatment. J Natl Cancer Inst 2006;98: 574-5. https://doi.org/10.1093/jnci/djj198
  36. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene. Science 1998;282:2085-8. https://doi.org/10.1126/science.282.5396.2085
  37. Hong S, Qian J, Yang J, Li H, Kwak LW, Yi Q. Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth. Cancer Res 2008;68:8456-64. https://doi.org/10.1158/0008-5472.CAN-08-2213

Cited by

  1. The Relationship between Opioids Use, Cortisol and DHEAS vol.18, pp.2, 2015, https://doi.org/10.14475/kjhpc.2015.18.2.105
  2. Analysis of Effect and Prognostic Factors Associated with Catheter Intervention on Ascites in Terminal Cancer Patient vol.19, pp.4, 2016, https://doi.org/10.14475/kjhpc.2016.19.4.303
  3. 입원 초기 지표를 통한 호스피스 환자의 퇴원 형태 예측 vol.21, pp.3, 2018, https://doi.org/10.14475/kjhpc.2018.21.3.75